RecruitingNCT07717255
Adequacy of Haemodiafiltration: Middle Molecules Clearance, Patients Reported Outcomes and Sodium Balance
Sponsor
East and North Hertfordshire NHS Trust
Enrollment
300 participants
Start Date
Jan 9, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to understand the differences in terms of middle molecules clearance and patient outcomes in High (\>23Litres (L)) vs Low (\<23 L) convection volume (CV) Hemodiafiltration (HDF) and to understand the effect of dialysate fluid sodium concentration (137 vs 140 mmol/L) on overhydration volume in patients on HD and HDF.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age 18 years or above.
- Ability to give informed consent.
- End stage kidney disease (ESKD) treated by haemodialysis for at least 3 months.
- Prognosis > 6 months as assessed by principal investigator (PI)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07717255
Related Trials
Stunting and Targeting Reduction of Impaired Growth in Kids Effectively
NCT075249071 location
Delivering Food Resources & Kitchen Skills (FoRKS) to Adults With Food Insecurity and Hypertension
NCT058565911 location
Eating Almonds Before a Meal to Control Blood Sugar
NCT076037391 location
Nutrition for Precision Health, Powered by the All of Us
NCT0570165714 locations
Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial
NCT070799951 location